Sumatriptan: efficacy and contribution to migraine mechanisms.
作者信息
Pearce J M
出版信息
J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1103-5. doi: 10.1136/jnnp.55.12.1103.
Abstract
摘要
相似文献
1
Sumatriptan: efficacy and contribution to migraine mechanisms.
J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1103-5. doi: 10.1136/jnnp.55.12.1103.
2
Sumatriptan for migraine.
Med Lett Drugs Ther. 1992 Oct 2;34(880):91-3.
3
Sumatriptan.
Lancet. 1993 Jan 23;341(8839):221-4. doi: 10.1016/0140-6736(93)90079-v.
4
Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
Cephalalgia. 1993 Aug;13(4):238-44. doi: 10.1046/j.1468-2982.1993.1304238.x.
5
Sumatriptan in acute migraine: pharmacology and review of world experience.
Headache. 1990;30 Suppl 2:554-60. doi: 10.1111/j.1526-4610.1990.hed30s2554.x.
6
Efficacy of 5HT in migraine.
Cephalalgia. 1999 Sep;19(7):625-6. doi: 10.1046/j.1468-2982.1999.1907625-2.x.
7
SUMATRIPTAN: a receptor-targeted treatment for migraine.
Annu Rev Med. 1993;44:145-54. doi: 10.1146/annurev.me.44.020193.001045.
8
Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
Cephalalgia. 1999 Jun;19(5):536-7. doi: 10.1177/033310249901900503.
9
Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
Pharmacol Rev. 1991 Dec;43(4):579-86.
10
Serotonin receptors and headache.
N Engl J Med. 1991 Aug 1;325(5):353-4. doi: 10.1056/NEJM199108013250509.
引用本文的文献
1
Headache.
J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):134-43. doi: 10.1136/jnnp.57.2.134.
本文引用的文献
1
Migraine: a cerebral disorder.
Lancet. 1984 Jul 14;2(8394):86-9. doi: 10.1016/s0140-6736(84)90252-6.
2
Historical aspects of migraine.
J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1097-103. doi: 10.1136/jnnp.49.10.1097.
3
The role of adenosine triphosphate in migraine.
Biomed Pharmacother. 1989;43(10):727-36. doi: 10.1016/0753-3322(89)90161-3.
4
Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks.
Cephalalgia. 1989 Mar;9(1):29-32. doi: 10.1046/j.1468-2982.1989.0901029.x.
5
Migraine--why and how a cortical excitatory wave may initiate the aura and headache.
Headache. 1991 Apr;31(4):213-21. doi: 10.1111/j.1526-4610.1991.hed3104213.x.
6
5-HT2 receptor antagonists and migraine therapy.
J Neurol. 1991;238 Suppl 1:S45-52. doi: 10.1007/BF01642906.
7
Neuroexcitatory plasma amino acids are elevated in migraine.
Neurology. 1990 Oct;40(10):1582-6. doi: 10.1212/wnl.40.10.1582.
8
5-Hydroxytryptamine and its role in migraine.
Eur Neurol. 1991;31(5):279-81. doi: 10.1159/000116754.
9
Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs.
Pain. 1991 Aug;46(2):125-132. doi: 10.1016/0304-3959(91)90066-7.
10
Oral sumatriptan in acute migraine.
Lancet. 1991 Sep 28;338(8770):782-3. doi: 10.1016/0140-6736(91)90666-d.
Zotero 插件